Electro-Optical Sciences Submits MelaFind(R) Pre-Market Approval Application to FDA
June 04, 2009 07:30 ET | Electro-Optical Sciences, Inc.
IRVINGTON, NY--(Marketwire - June 4, 2009) - Electro-Optical Sciences, Inc. ("EOS") (NASDAQ: MELA) today announced the submission to the United States Food and Drug Administration (FDA) of its...
May Is Melanoma/Skin Cancer Detection and Prevention Month(R)
May 04, 2009 16:37 ET | AAD
SCHAUMBURG, IL--(Marketwire - May 4, 2009) - In recognition of Melanoma/Skin Cancer Detection and Prevention Month®, the American Academy of Dermatology (Academy) releases skin cancer news and...
Electro-Optical Sciences to Commemorate Melanoma Monday at NASDAQ Stock Market
April 30, 2009 16:01 ET | Electro-Optical Sciences, Inc.
IRVINGTON, NY--(Marketwire - April 30, 2009) - Electro-Optical Sciences (NASDAQ: MELA) today announced that the company will ring the NASDAQ Stock Market Opening Bell on Monday, May 4, 2009 at 9:30...
Electro-Optical Sciences Announces Additional Data From MelaFind(R) Pivotal Study Presented at American Academy of Dermatology Meeting
March 12, 2009 07:30 ET | Electro-Optical Sciences, Inc.
IRVINGTON, NY--(Marketwire - March 12, 2009) - Electro-Optical Sciences, Inc. (EOS) (NASDAQ: MELA) today announced that additional data on MelaFind®, the company's non-invasive, point-of-care...
Electro-Optical Sciences Announces Positive Top-Line Results From Landmark MelaFind(R) Pivotal Trial
February 13, 2009 06:00 ET | Electro-Optical Sciences, Inc.
IRVINGTON, NY--(Marketwire - February 13, 2009) - Electro-Optical Sciences, Inc. ("EOS") (NASDAQ: MELA) today announced positive top-line results of its pivotal trial of MelaFind, a non-invasive,...
Electro-Optical Sciences Announces Participation at the 11th Annual Needham Growth Stock Conference
December 31, 2008 08:30 ET | Electro-Optical Sciences, Inc.
IRVINGTON, NY--(Marketwire - December 31, 2008) - Electro-Optical Sciences, Inc. ("EOS") (NASDAQ: MELA), a medical device company focused on the design and development of MelaFind®, a...
Electro-Optical Sciences Provides MelaFind(R) Development Update
December 29, 2008 14:45 ET | Electro-Optical Sciences, Inc.
IRVINGTON, NY--(Marketwire - December 29, 2008) - Electro-Optical Sciences, Inc. ("EOS") (NASDAQ: MELA), a medical device company focused on the design and development of MelaFind®, a...
AAD Launches PSA Campaign on Dangers of Indoor Tanning
May 05, 2008 13:17 ET | AAD
SCHAUMBURG, IL--(Marketwire - May 5, 2008) - In recognition of Melanoma/Skin Cancer Detection and Prevention Month®, the American Academy of Dermatology (Academy) releases a new public service...
Additional Orphan Drug Status Granted for Melanoma for Marshall Edwards' Investigational Anti-Cancer Drug Triphendiol (NV-196)
February 19, 2008 07:31 ET | Marshall Edwards, Inc.
NEW CANAAN, CT--(Marketwire - February 19, 2008) - Marshall Edwards, Inc., (NASDAQ: MSHL) announced today that triphendiol (previously known as NV-196) has been granted Orphan Drug status by the U.S....